Company / Profit Margin
Cue Biopharma, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-96.9%
FY2025
5-year range
-4257.8% / -96.9%
FY2021-FY2025
Trend
+77.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 3 consecutive years, from -4257.8% in FY2022 to -96.9% in FY2025.
Based on SEC 10-K filings.
-96.9% in FY2025 with a 5-year CAGR of +964.3%.
Improved from -924.1% to -96.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +4161.0pp
- 5-Year Change
- +964.3pp
- 10-Year Change
- -
Key checks
Key Insights
- Cue Biopharma, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 77.9% year-over-year.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -96.9% | +77.9% |
| FY2024 | -438.0% | +52.6% |
| FY2023 | -924.1% | +78.3% |
| FY2022 | -4257.8% | -1340.6% |
| FY2021 | -295.6% | +72.1% |
| FY2020 | -1061.2% | +68.9% |
| FY2019 | -3411.5% | -67.8% |
| FY2018 | -2033.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026